Nissim Benvenisty

Prof. Nissim Benvenisty


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2018 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
AYAtilgan Yilmaz
Atilgan Yilmaz
MPMordecai Peretz
Mordecai Peretz
AAAviram Aharony
Aviram Aharony
ISIdo Sagi
Ido Sagi
NBNissim Benvenisty
Nissim Benvenisty

1 February 2016 in Cell Stem Cell
Verified
Journal Article
Closed access
NLNoa Lamm
Noa Lamm
UBUri Ben-David
Uri Ben-David
TGTamar Golan-Lev
Tamar Golan-Lev
Zuzana StorchovaZuzana Storchova
Zuzana Storchova
NBNissim Benvenisty
Nissim Benvenisty
K Batsheva Kerem
Batsheva Kerem

14 May 2019 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
SBShiran Bar
Shiran Bar
NBNissim Benvenisty
Nissim Benvenisty
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 May 2017 in Cell Reports
Verified
Journal Article
Open access
SBShiran Bar
Shiran Bar
MSMaya Schachter
Maya Schachter
TETalia Eldar-Geva
Talia Eldar-Geva
NBNissim Benvenisty
Nissim Benvenisty
The parent-specific monoallelic expression of imprinted genes is controlled by DNA methylation marks that are established differentially in the germline. Perturbation of these marks leads to loss of imprinting (LOI), which is associated with developmental disorders and malignancy and may also obstruct applications of human pluripotent stem cells (hPSCs). Previous studies of LOI in hPSCs were performed on relatively small numbers of cell lines, often leading to conflicting conclusions regarding imprinting stability. Here, we chart the landscape of LOI in hPSCs by applying a large-scale analysis of allele-specific RNA-seq data from more than 270 hPSC samples. We show that reprogrammed hPSCs acquire higher levels of LOI compared with embryonic stem cells and that LOI can pre-exist in their somatic cells of origin. Furthermore, different imprinted genes vary with respect to LOI incidence, surprisingly revealing that those controlled paternally are more prone to disruption. Our findings emphasize the importance of inspecting the imprinting status of hPSCs.

1 July 2019 in Cell Stem Cell
Verified
Journal Article
Closed access
AYAtilgan Yilmaz
Atilgan Yilmaz
NBNissim Benvenisty
Nissim Benvenisty

1 April 2019 in Cell Reports
Verified
Journal Article
Open access
SBShiran Bar
Shiran Bar
LSLev Roz Seaton
Lev Roz Seaton
UWUri Weissbein
Uri Weissbein
TETalia Eldar-Geva
Talia Eldar-Geva
NBNissim Benvenisty
Nissim Benvenisty
Dosage compensation of sex-chromosome gene expression between male and female mammals is achieved via X chromosome inactivation (XCI) by employing epigenetic modifications to randomly silence one X chromosome during early embryogenesis. Human pluripotent stem cells (hPSCs) were reported to present various states of XCI that differ according to the expression of the long non-coding RNA XIST and the degree of X chromosome silencing. To obtain a comprehensive perspective on XCI in female hPSCs, we performed a large-scale analysis characterizing different XCI parameters in more than 700 RNA high-throughput sequencing samples. Our findings suggest differences in XCI status between most published samples of embryonic stem cells (ESCs) and induced PSCs (iPSCs). While the majority of iPSC lines maintain an inactive X chromosome, ESC lines tend to silence the expression of XIST and upregulate distal chromosomal regions. Our study highlights significant epigenetic heterogeneity within hPSCs, which may bear implications for their use in research and regenerative therapy.